The pharmacological treatment of patients with chronic
heart failure has changed dramatically over the past 25
years. This change began with the demonstration of
the beneficial effects of the combination of hydralazine and
isosorbide dinitrate in the V-HeFT-I (Veterans Administration
Co-operative Study) trial.
NICE try but a long way to go in heart failure
September 2004Br J Cardiol 2004;11:339-41 Leave a commentClick any image to enlarge